Comment by
Noteable on Sep 02, 2022 12:33pm
Pfizer's acquisition of ONCY at this time in pelareorep's advanced clinical development stage would give both Andy Schmeltz, Pfizer's new VP Commercial Strategy and Innovation, and Sunetet Varma, Pfizer's new Global Oncology Chief and US President, and early win in their new roles.
Comment by
Noteable on Sep 04, 2022 9:38am
This news came out last week .... showing that Big Pharma like Pfizer is getting prepared for some serious M&A activity in immuno-oncology in the near future.